By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AdkhabarAdkhabarAdkhabar
Notification Show More
Font ResizerAa
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Reading: Marengo Asia Hospitals acquires majority stake in 350-bed Sunshine Global Hospitals
Share
Font ResizerAa
AdkhabarAdkhabar
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Search
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Follow US
Adkhabar > Blog > News > Marengo Asia Hospitals acquires majority stake in 350-bed Sunshine Global Hospitals
Marengo Asia Hospitals acquires majority stake in 350-bed Sunshine Global Hospitals
News

Marengo Asia Hospitals acquires majority stake in 350-bed Sunshine Global Hospitals

Last updated: 17/10/2025 5:37 PM
Published: 17/10/2025
Share
SHARE

NEW DELHI, Oct. 17, 2025 /PRNewswire/ — Marengo Asia Hospitals has further strengthened its Western India footprint with majority acquisition of Sunshine Global Hospitals — a prominent multi-specialty hospital chain in Gujarat with presence in Surat and Vadodara and a combined capacity of 350 beds. Both hospital units are NABH-accredited and offer more than 20 super-specialties.

- Advertisement -

Marengo Asia Hospitals focuses on providing tertiary and quaternary care, creating ‘Centers of Excellence’ across medical specialties, and adopting a ‘patient first’ approach. This acquisition further consolidates its presence in Gujarat where it already has two facilities located in Ahmedabad and Bhuj.

- Advertisement -

This acquisition follows Marengo Asia Hospitals’ recent expansions into Varanasi with Metis-The Medicity, marking its entry into a new state (Uttar Pradesh), and into the Kingdom of Saudi Arabia (KSA), marking its first international collaboration with Specialized Najran Hospital. With all these additions, Marengo Asia Hospitals now operates a total of 8 hospitals with a cumulative capacity of 2,500 beds, supported by a team of over 900 doctors and 5,200 employees.

- Advertisement -

“As we expand our presence in Western India, we are excited to enter 2 prominent cities of Vadodara and Surat and bring in our advanced tertiary and quaternary care expertise to the people of these cities and nearby areas,” said Dr. Raajiv Singhal, Founding Member, Managing Director and Group CEO, Marengo Asia Hospitals. “Every new hospital we bring into the Marengo Asia Hospitals’ network strengthens our commitment to the ‘Patient First’ approach — making specialized, affordable, and compassionate care accessible to more people, closer to their homes. Marengo Asia Hospitals aims to grow sustainably by developing clinical Centers of Excellence across specialties to deliver the best clinical outcomes for its patients.”

- Advertisement -

About Marengo Asia Hospitals:

- Advertisement -

Marengo Asia Hospitals with its headquarter in NCR is a multi-specialty hospital chain focused on providing tertiary and quaternary care, creating ‘Centers of Excellence’ across medical specialties, and adopting a ‘Patient First’ approach. Its hospital network is currently spread across Northern and Western India. Marengo Asia Hospitals is founded and backed by Samara Capital, Havells and Godrej family offices and Dr Raajiv Singhal and is one of the fastest growing unlisted hospital chains with a revenue run-rate of ~ INR 1,200crs p.a.

- Advertisement -

Photo: https://mma.prnewswire.com/media/2798998/MAH_SGH_Deal_Signing.jpg

- Advertisement -

 

- Advertisement -

View original content to download multimedia:https://www.prnewswire.com/in/news-releases/marengo-asia-hospitals-acquires-majority-stake-in-350-bed-sunshine-global-hospitals-302587386.html

- Advertisement -
ImmunityBio Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ImmunityBio, Inc. – IBRX
HCLTech Q3 FY26 revenue up 4.2% QoQ (CC) as annualized revenue crosses $15B; bookings exceptionally high at $3B
UnionPay Launches Global Summer Campaign with Exclusive Travel Offers
Heidi Hunter Appointed New Vice Chair of the Board of Directors of Bavarian Nordic
Lantronix Announces Preliminary Inclusion in Russell 3000 Index
TAGGED:350-bedacquiresasiaglobalhospitalsmajoritymarengonewsstake,sunshine
Share This Article
Facebook Email Print
- Advertisement -

Follow US

Find US on Social Medias
FacebookLike
XFollow
YoutubeSubscribe

Weekly Newsletter

Subscribe to our newsletter to get our newest articles instantly!
Popular News
Corvus Pharmaceuticals to Announce Results from Cohort 4 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis
Health

Corvus Pharmaceuticals to Announce Results from Cohort 4 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis

GlobeNews Wire
GlobeNews Wire
18/01/2026
First qualification systems for LA28 approved
G42 and Vietnamese Consortium Commit to Build National AI Infrastructure and Develop Southeast Asia’s Intelligence Capacity
Medidata and the University of Sydney’s NHMRC Clinical Trials Centre Broaden Efforts to Revolutionize Clinical Studies in Australia
Kia Announces Pricing for 2026 Sorento HEV
- Advertisement -
- Advertisement -
- Advertisement -

Categories

  • Automobile
  • Entertainment
  • E-Sports
  • Food
  • Health
  • Technology
  • LifeStyle
  • Travel

About Us

Through our news networks, we raise millions of users' awareness. We are among the world's most reputable news networks.
Quick Link
Top Categories
  • Entertainment

Subscribe US

Subscribe to our newsletter to get our newest articles instantly!

AdkhabarAdkhabar
Copyright © 2021 - 2025 AdKhabar. All Rights Reserved. POWERED BY Life Care News.
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?